Thursday, April 29, 2021

Still Protected! Medicare's Six Protected Drug Classes Policy Survives Trump's Attack

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association In the waning days of the Trump Administration, Medicare Part D once again faced a se...
Thursday, April 22, 2021

New CDC Surveillance Reveals Risks Among Transgender Women, Including HIV

›
By: Jen Laws, Board Member, ADAP Advocacy Association, and HIV/transgender health advocate   On April 15, 2021, the U.S. Centers for Disease...
Thursday, April 15, 2021

It Is Time to Advocate for the Patient

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association        Jeffrey R. Lewis, President & CEO, Legacy Health Endowment         (The vi...
Thursday, April 8, 2021

Cabenuva is a Shot 💉 of Hope for People Living with HIV/AIDS

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association On January 21, 2021, a shot of hope was provided by the U.S. Food & Drug Administ...
Thursday, April 1, 2021

Fake Symtuza® Serves as Wake-Up Call Over Counterfeit HIV Medications

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association For over a decade counterfeit drugs have been a concern of the ADAP Advocacy Associat...
Thursday, March 25, 2021

Making U=U Foundational in Our Efforts to End the HIV Epidemic

›
By: Murray Penner, U.S, Executive Director, Prevention Access Campaign/U=U Undetectable = Untransmittable, or U=U, was created in July 2016,...
Thursday, March 18, 2021

Immunocompromised: Get Your Covid-19 Vaccine

›
By: Brandon M. Macsata, CEO, ADAP Advocacy Association On March 2, 2021, President Joseph R. Biden announced the United States would have en...